🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to show that subcutaneous (SC) administration ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-10-27
Trial ID
NCT03277105
The purpose of this study is to evaluate the tolerability and safety of sub...
Status
Completed
Location
National Hospital Organization Shibukawa Medical Center
Start Date
2017-08-10
Trial ID
NCT03242889
Treatments Being Tested
This phase II trial tests daratumumab given at a reduced frequency with len...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2026-04-20
Trial ID
NCT07485647
Treatments Being Tested
Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but ...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2019-08-13
Trial ID
NCT04071457
Treatments Being Tested
This phase I trial studies the possible benefits and side effects of adding...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-09-27
Trial ID
NCT04956302
Treatments Being Tested
The primary objective of this study is to determine whether treatment with ...
Status
Completed
Location
Arizona Oncology Associates, PC - HAL
Start Date
2017-11-07
Trial ID
NCT03301220
Treatments Being Tested
This is an open-label, multicenter, Phase 2 study in subjects with newly di...
Status
Completed
Location
Hopitaux Universitaires Henri-Mondor
Start Date
2019-09-23
Trial ID
NCT04131309
Treatments Being Tested
This phase III trial compares the combination of four drugs (daratumumab, b...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-02-24
Trial ID
NCT04566328
This phase I trial studies the side effects and best dose of selvigaltin wh...
Status
Withdrawn
Location
Roswell Park Cancer Institute
Start Date
2026-04-01
Trial ID
NCT07082270
Treatments Being Tested
The purpose of this study is to evaluate the safety and pharmacokinetic of ...
Status
Completed
Location
Peking University Third Hospital
Start Date
2019-12-25
Trial ID
NCT04121260
Treatments Being Tested